← Back to Clinical Trials
Recruiting NCT07254910

NCT07254910 Feasibility of a Multi-Channel Intervention to Promote Colorectal Cancer Screening Among American Indians in Oklahoma

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07254910
Status Recruiting
Phase
Sponsor University of Oklahoma
Condition CRC Screening
Study Type INTERVENTIONAL
Enrollment 150 participants
Start Date 2026-05-30
Primary Completion 2026-09-30

Eligibility & Interventions

Sex All sexes
Min Age 45 Years
Max Age 75 Years
Study Type INTERVENTIONAL
Interventions
Narrative Testimonial Videov-TCHE Interaction

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 150 participants in total. It began in 2026-05-30 with a primary completion date of 2026-09-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The Accelerating Colorectal Cancer Screening and follow-up through Implementation Science (ACCSIS) Program addresses major regional CRC screening disparities among AI in Oklahoma. The investigators are engaged in a participatory and collaborative effort with Tribal Nations, Area Indian Health Boards, and Indian Health Service (IHS) healthcare facilities. The overall objective of this proposal is to leverage these relationships and examine the feasibility of co-developing and disseminating a v-TCHE as part of a multi-channel communication intervention. To achieve this objective, the investigators have partnered with IHS Clinton Service Unit, which serves members of the Cheyenne and Arapaho Tribes. The intervention will be disseminated across two channels: (1) Social Media (i.e., accessed via online study adverts) and (2) Clinic (i.e., direct messaging to patients via a study link in a SMS text). Across both channels, the investigators will examine reach of the intervention and its potential efficacy via a randomized controlled trial. Once participants click on the study link they will be randomized 1:1 to one of two intervention conditions: (1) watch a Narrative Testimonial Video of a real-life Tribal community health educator (control) or (2) an interaction with a v-TCHE. Participants will then complete a post-intervention survey, in which they can click to order a FIT kit afterwards.

Eligibility Criteria

Inclusion Criteria: * Age 45-75 Live within IHS Clinton Service Unit catchment area Fluent in English and read at or above 6th grade level Self report as American Indian or have CDIB Exclusion Criteria: * Self report up to date with CRC screening FIT within 1 year

Contact & Investigator

Central Contact

Jordan Neil, PhD

✉ jordan-neil@ou.edu

📞 (405) 271-5046

Principal Investigator

Jordan Neil, PhD

PRINCIPAL INVESTIGATOR

University of Oklahoma

Frequently Asked Questions

Who can join the NCT07254910 clinical trial?

This trial is open to participants of all sexes, aged 45 Years or older, up to 75 Years, studying CRC Screening. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07254910 currently recruiting?

Yes, NCT07254910 is actively recruiting participants. Contact the research team at jordan-neil@ou.edu for enrollment information.

Where is the NCT07254910 trial being conducted?

This trial is being conducted at Oklahoma City, United States.

Who is sponsoring the NCT07254910 clinical trial?

NCT07254910 is sponsored by University of Oklahoma. The principal investigator is Jordan Neil, PhD at University of Oklahoma. The trial plans to enroll 150 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology